Location: South San Francisco, CA
Position Summary
Reporting directly to the Vice President, Portfolio Strategy and Operations, the Head of the Program Management Office will lead the program manager team, work with functional leaders to set and achieve program goals and shape the Annexon pipeline. You will ensure that the program management office coordinates, tracks and helps advance both program activities as well as activities of internal functional areas (as needed), external collaborators and service providers to achieve program milestones/goals and corporate objectives. You will leverage a strong scientific background, coupled with excellent leadership and project management skills. In this role, you will consistently and effectively communicate with senior members of management, and others, regarding program strategies, resources, timelines, etc. You will be a key resource in proactively integrating multiple functions and activities, as well as proactively identifying and helping to drive decision making and resolution of program related matters and the overall Annexon portfolio as appropriate. This role will be part of the Annexon Leadership team.
Responsibilities
Key Qualifications
What Annexon offers
Compensation
The anticipated starting salary for the Vice President (VP), PMO Leader position is $320,900 – $344,400 per year. The starting salary for this position will be determined based on the candidate’s education, experience, transferable skills, licenses/certifications, location, and will be reviewed on a case-by-case basis to determine the final compensation. The starting salary does not include any other potential components of the total compensation package, including bonus, equity, employer provided benefits, and perks.
Company Summary
Annexon Biosciences is a clinical-stage biopharmaceutical company seeking to bring game-changing medicines to patients with classical complement-mediated diseases of the body, brain and eye. The classical complement cascade is a seminal pathway within the immune system that anchors and drives a host of autoimmune, neurodegenerative and ophthalmic diseases. Annexon is advancing a new class of complement medicines targeting the early classical cascade and all downstream pathway components that contribute to disease, while selectively preserving the beneficial immune functions of other complement pathways. Annexon is rigorously developing a pipeline of diversified product candidates across multiple mid- to late-stage clinical trials, with clinical data anticipated throughout 2023 and beyond.
EEO Employer – Annexon highly values Diversity, Equity, Inclusion and Belonging
Annexon Biosciences is an Equal Opportunity Employer and does not discriminate against any employee or applicant for employment based on race, color, religion, national origin, age, gender, sex, ancestry, citizenship status, mental or physical disability, genetic information, sexual orientation, veteran status, or military status. We are proud to promote a work environment where everyone, from any background, can do their best work.
Staffing Agencies
Annexon Biosciences does not accept unsolicited agency resumes and will not pay fees to any third-party agency or firm that doesn’t have a signed agreement with Annexon Biosciences or submits and candidate without an approved job req assignment. Please do not send agency CVs/resumes through Annexon’s website or Annexon Employees. Inquiries must be sent to talentacquisition@annexonbio.com with the Subject Heading: Staffing Agency Request.
Annexon is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status.